A Klotho-Derived Peptide as a Possible Novel Drug to Prevent Kidney Fibrosis

Am J Kidney Dis. 2022 Aug;80(2):285-288. doi: 10.1053/j.ajkd.2022.03.006. Epub 2022 Apr 22.

Authors

Tamara Isakova¹, Christopher Yanucil², Christian Faul²

Affiliations

¹ Division of Nephrology and Hypertension, Department of Medicine and Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: tamara.isakova@northwestern.edu.
² Section of Mineral Metabolism, Division of Nephrology, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama.

PMID: 35469964
DOI: 10.1053/j.ajkd.2022.03.006

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Comment

MeSH terms

Fibrosis
Glucuronidase
Humans
Kidney / pathology
Kidney Diseases* / pathology
Peptides

Substances

Peptides
Glucuronidase

Grants and funding